Abstract

Khushboo Vaghela*, Ansoya Chaudhari, Dhruvi Kavar, Parth Bhatt, Divyakant Patel

ABSTRACT

Emblica officinalis Gaertn. (syn. Phyllanthus emblica), commonly known as Amla, is a highly valued medicinal plant belonging to the family Euphorbiaceous and is widely distributed in tropical and subtropical regions of India and other Asian countries. Traditionally known as Amalaki in Sanskrit, it has been extensively used in Ayurveda as a potent rasayana for rejuvenation and treatment of various disorders such as diarrhoea, jaundice, inflammation, and metabolic imbalances. Almost all parts of the plant including fruits, seeds, leaves, root bark, and flowers possess therapeutic importance, with the fruit being the most widely utilized. Phytochemical investigations reveal that Amla is rich in tannins, phenolic compounds, flavonoids, alkaloids, and hydrolysable tannins such as Emblicanin A and Emblicanin B, which yield gallic acid and ellagic acid on hydrolysis. The fruit also contains rutin, quercetin, corilagin, geraniin, and exhibits a very high concentration of vitamin C. Due to this diverse chemical composition, E. officinalis demonstrates broad pharmacological activities including antioxidant, anti-inflammatory, analgesic, cardioprotective, and free radical scavenging properties. Additionally, Amla forms an essential component of the classical Ayurvedic formulation Triphala, along with Terminalia chebula and Terminalia bellirica, which is widely used for detoxification, digestive health, and immune enhancement. Several studies also highlight the chemopreventive potential of Triphala and Amla in cancer models by improving antioxidant defense and reducing tumor incidence. Overall, Emblica officinalis remains an important medicinal plant with promising therapeutic applications and significant potential for modern drug development.